News

Medically reviewed by Kira Graves, PhD Severe autism, or level 3 autism spectrum disorder (ASD), describes individuals with the highest support needs on the autism spectrum. Individuals with level 3 ...
Tuberous sclerosis complex is a multisystemic, autosomal dominant genetic disorder with complete penetrance, that can evolve with hamartomas in multiple organs, such as skin, central nervous system, ...
A garden that was designed to raise awareness for the Tuberous Sclerosis Association has won a gold medal at the RHS Chelsea Flower Show. Jen Donnelly and Catherine Gibbon volunteer at Amersham ...
A garden that was designed to raise awareness for the Tuberous Sclerosis Association has won a gold medal at the RHS Chelsea Flower Show. Jen Donnelly and Catherine Gibbon volunteer at Amersham ...
Tuberous sclerosis is a rare genetic condition that causes mainly benign tumours to develop in different parts of the body, such as the brain, heart, and lungs.
On May 15, the TSC Alliance® will join tuberous sclerosis complex (TSC) organizations around the world to observe the 13th Annual TSC Global Awareness Day. On this day, thousands of individuals ...
May is Tuberous Sclerosis awareness month. The rare genetic disorder causes non-cancerous tumours to form in many parts of the body. Klaudia Van Emmerik has more.
Pavan Bhargava, MD, reflects on key takeaways from the AAN 2025 conference, specifically, the updated diagnostic criteria for relapsing-remitting multiple sclerosis, which facilitate earlier ...
In the atypical cohort, these criteria were met by 15%, 38%, and 36%, respectively. In the radiological-only cohort, the corresponding proportions were 8%, 58%, and 25%, respectively.
CBD-Based Life-Changing Drug For Tuberous Sclerosis Patients, Epidiolex, Now Available Via England’s NHS; JAZZ Jazz Pharmaceuticals PLC. $108.29 0.73 % Stock Score Locked: Edge Members Only.
References: Marinus pharmaceuticals announces topline results from phase 3 TrustTSC trial of oral ganaxolone in tuberous sclerosis complex and commences process to explore strategic alternatives.